Minisini AM - Search Results

1

Immunotherapy for older patients with melanoma: From darkness to light?

Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, Pascoletti G, Minisini AM. Iacono D, et al. Among authors: minisini am. Pigment Cell Melanoma Res. 2021 May;34(3):550-563. doi: 10.1111/pcmr.12917. Epub 2020 Aug 18. Pigment Cell Melanoma Res. 2021. PMID: 32745351 Review.

2

Analysis of workload generated in the two years following first consultation by each new cancer patient: studying the past to plan the future of cancer care.

Garattini SK, Valent F, Minisini AM, Riosa C, Favaretti C, Regattin L, Fasola G. Garattini SK, et al. Among authors: minisini am. BMC Health Serv Res. 2022 Sep 21;22(1):1184. doi: 10.1186/s12913-022-08573-3. BMC Health Serv Res. 2022. PMID: 36131286 Free PMC article.

3

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse P, Piccart MJ; EORTC Breast Cancer and Early Clinical Studies Groups. Atalay G, et al. Eur J Cancer. 2003 Nov;39(17):2439-49. doi: 10.1016/s0959-8049(03)00601-4. Eur J Cancer. 2003. PMID: 14602130 Review.

4

Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.

Minisini A, Spazzapan S, Crivellari D, Aapro M, Biganzoli L. Minisini A, et al. Crit Rev Oncol Hematol. 2005 Feb;53(2):125-31. doi: 10.1016/j.critrevonc.2004.11.003. Crit Rev Oncol Hematol. 2005. PMID: 15661563

5

Remaining controversies in the upfront management of advanced ovarian cancer.

Mano MS, Awada A, Minisini A, Atalay G, Lago LD, Cardoso F, Piccart M. Mano MS, et al. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):707-20. doi: 10.1111/j.1048-891X.2004.014502.x. Int J Gynecol Cancer. 2004. PMID: 15361178 Review.

6

Exquisite antitumour response to trastuzumab in a patient with no evidence of Ras-Raf-MAPK and PI3K-Akt pathways activation.

Mano MS, Awada A, Minisini A, Durbecq V, Di Leo A, Piccart M. Mano MS, et al. Breast. 2004 Aug;13(4):347-9. doi: 10.1016/j.breast.2003.11.009. Breast. 2004. PMID: 15325672

7

Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer.

Minisini AM, Di Loreto C, Mansutti M, Artico D, Pizzolitto S, Piga A, Puglisi F. Minisini AM, et al. Cancer Lett. 2005 Jun 16;224(1):133-9. doi: 10.1016/j.canlet.2004.11.007. Epub 2004 Dec 13. Cancer Lett. 2005. PMID: 15911109

8

Chemotherapy for metastatic breast cancer.

Biganzoli L, Minisini A, Aapro M, Di Leo A. Biganzoli L, et al. Curr Opin Obstet Gynecol. 2004 Feb;16(1):37-41. doi: 10.1097/00001703-200402000-00008. Curr Opin Obstet Gynecol. 2004. PMID: 15128006 Review.

9

Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study.

Minisini AM, De Faccio S, Ermacora P, Andreetta C, Fantinel R, Balestrieri M, Piga A, Puglisi F. Minisini AM, et al. Crit Rev Oncol Hematol. 2008 Jul;67(1):71-9. doi: 10.1016/j.critrevonc.2008.02.004. Epub 2008 Apr 3. Crit Rev Oncol Hematol. 2008. PMID: 18394917

10

Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.

Puglisi F, Follador A, Minisini AM, Cardellino GG, Russo S, Andreetta C, Di Terlizzi S, Piga A. Puglisi F, et al. Among authors: minisini am. Ann Oncol. 2005 Feb;16(2):263-6. doi: 10.1093/annonc/mdi063. Ann Oncol. 2005. PMID: 15668281 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page